| Medically refractory neurosarcoidosis treated with infliximab. | |
| | |
MedLine Citation:
|
PMID: 21507165 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Neurosarcoidosis can worsen despite standard immunosuppressive therapy, a situation for which there is no established medical management. We present three cases of medically refractory neurosarcoidosis treated with infliximab. All three patients showed a clinical response to this treatment and side effects were limited. A summary of reported cases of neurosarcoidosis treated with infliximab is included. This case series supports a role for infliximab in the treatment of patients with medically refractory neurosarcoidosis. |
| | |
Authors:
|
J Pereira; N E Anderson; D McAuley; P Bergin; D Kilfoyle; J Fink |
Related Documents
:
|
21426375 - Factors associated with dropout in medical education: a literature review. 21514485 - Policy implications of oral agents. 21545445 - An interactional approach to conceptualising small talk in medical interactions. 21518115 - Medication errors--new approaches to prevention. 17005045 - Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical in... 1120755 - Maximal aerobic capacity at different levels of carboxyhemoglobin. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: Internal medicine journal Volume: 41 ISSN: 1445-5994 ISO Abbreviation: Intern Med J Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-04-21 Completed Date: 2012-03-06 Revised Date: 2012-03-29 |
Medline Journal Info:
|
Nlm Unique ID: 101092952 Medline TA: Intern Med J Country: Australia |
Other Details:
|
Languages: eng Pagination: 354-7 Citation Subset: IM |
Copyright Information:
|
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians. |
Affiliation:
|
Department of Medicine, University of Auckland Department of Neurology, Auckland City Hospital, Auckland, New Zealand. j.pereira@auckland.ac.nz |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antibodies, Monoclonal / administration & dosage* Central Nervous System Diseases / diagnosis*, drug therapy*, immunology Drug Administration Schedule Drug Resistance / drug effects, immunology Female Follow-Up Studies Humans Immunosuppressive Agents / administration & dosage Male Sarcoidosis / diagnosis*, drug therapy*, immunology Treatment Outcome Tumor Necrosis Factor-alpha* / immunology |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Immunosuppressive Agents; 0/Tumor Necrosis Factor-alpha; 0/infliximab |
| Comments/Corrections | |
Comment In:
|
Intern Med J. 2012 Feb;42(2):232
[PMID:
22356508
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prevalence and molecular study of G6PD deficiency in Malaysian Orang Asli.
Next Document: Blood transfusion: old blood, new blood or no blood.